Polypharmacy: America’s other drug problem-Reference-Cited by-同舟云学术

Polypharmacy: America’s other drug problem

Published:2017-09-01 Issue:17 Volume:74 Page:1305-1306
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Guharoy Roy¹

Affiliation:

1. Ascension Health St. Louis, MO, University of Massachusetts Memorial Medical School Worcester, MA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/17/1305/28336067/ajhp1305.pdf

Reference13 articles.

1. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids;Manchikanti;Pain Physician,2008

2. Quantifying opportunities to affect diabetes management in the community;Shiu;Can Pharm J,2006

3. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 v. 2011;Qato;JAMA Intern Med,2016

4. U.S. emergency department visits for outpatient adverse drug events, 2013–2014;Shehab;JAMA,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying network analysis to investigate substance use symptoms associated with drug overdose;Drug and Alcohol Dependence;2022-05

2. Longitudinal association between polypharmacy and development of pruritus: a Nationwide Cohort Study in a Japanese Population;Journal of the European Academy of Dermatology and Venereology;2021-06-23

3. Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial;Scientia Pharmaceutica;2020-10-20

4. Prevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results;Scientia Pharmaceutica;2020-09-23

5. Mixed Bag “Polypharmacy”: Methodological Pitfalls and Challenges of This Exposure Definition;Current Epidemiology Reports;2019-07-22